With the recent release of the movie “Vaxxed: From Cover-Up to Catastrophe,” I’m seeing a few blog posts and articles pop up about the hegemonic Read More
The data support the future co-administration of IPV, measles–rubella, and yellow fever vaccines within the Expanded Programme on Immunization schedule at 9 months. The administration of single fractional intradermal doses of IPV by needle and syringe or disposable-syringe jet injector compromises the immunity generated, although it results in a high post-vaccination poliovirus seroprevalence.
Washington Post: A yellow fever epidemic in Angola could turn into a global crisis “…More than 3,000 suspected cases are in Angola and 1,000 are in neighboring Congo, making this the biggest urban epidemic in decades. More than 400 people have died. There are growing concerns that Chinese workers — of whom there are thousands…More
By Aaron Ross KINSHASA (Reuters) — Democratic Republic of the Congo has almost run out of yellow fever vaccine in Kinshasa, in the same week that the government declared an epidemic of the disease in the packed capital and two other provinces. Some local people have complained they were denied immunization due to the shortage,
Many women from high-income and upper-middle-income countries have been vaccinated against HPV. However, populations with the highest incidence and mortality of disease remain largely unprotected. Rapid roll-out of the vaccine in low-income and middle-income countries might be the only feasible way to narrow present inequalities in cervical cancer burden and prevention.
Reuters: GAVI alliance offers matched funds for GSK malaria vaccine pilot “The GAVI global vaccine alliance has offered funding of up to $27.5 million for pilot tests of GlaxoSmithKline’s first-generation malaria vaccine, but only if other organizations promise to match that commitment…” (Kelland, 6/23).
Cervical cancer is the fourth most common cancer in women globally, but remains the second most common cancer (after breast cancer) in many low-income and middle-income countries, and is still more common than breast cancer in sub-Saharan Africa.1 Most new cervical cancer cases (85%) and deaths (88%) occur in low-income and middle-income countries, where health systems are often fragmented or fragile, and where most have not yet implemented effective national cervical cancer screening programmes.
Reuters: Congo declares yellow fever epidemic, 67 recorded cases “Democratic Republic of Congo declared a yellow fever epidemic in three provinces including the capital Kinshasa on Monday, after recording 67 cases of the disease. Health Minister Felix Kabange said seven of the cases were autochthonous, while 58 were imported from Angola, where the outbreak began…”…More
The Lancet: Yellow fever continues to spread in Angola “Although an emergency meeting of health experts last month stopped short of calling the yellow fever outbreak in Angola a global public health emergency, humanitarian groups on the ground warn the epidemic is still far from over. Even as the number of newly reported cases declines,…More
Seroepidemiology, the use of data on the prevalence of bio-markers of infection or vaccination, is a potentially powerful tool to understand the epidemiology of infection before vaccination and to monitor the effectiveness of vaccination programs.
Associated Press: Indian city on alert as polio strain found in sewage water “A city of nearly seven million people in southern India has declared a ‘high alert’ for polio after an active strain of the virus was found in samples of sewage water, an official said Wednesday…” (Farooq, 6/15). VOA News: India: Traces of…More
Bill & Melinda Gates Foundation’s “Impatient Optimists”: World Takes Major Step Towards Ending Polio Suchita Guntakatta, deputy director of strategy planning and management for the global development polio team at the Gates Foundation, discusses her work with colleagues in Kenya as they participated in last month’s global switch in oral polio vaccines (6/14).
Bill & Melinda Gates Foundation’s “Impatient Optimists”: Vaccine against Toxic Shock Syndrome successfully tested in a Phase I trial Melvin Sanicas, global health fellow and program officer with the Gates Foundation, discusses toxic shock syndrome (TSS) and research into an experimental vaccine (6/13).
Read more here: Vaccine against Toxic Shock Syndrome successfully tested in a Phase I trial